ARICH Business Summary

Arich Enterprise Co., Ltd. (4173.TWO) operates as Taiwan’s largest local pharmaceutical marketing and distribution service provider, utilizing a value-chain business model that generates revenue through specialized medical promotion, logistics services, and wholesale transactions. The company is structured into three primary segments: Sales Promotion, which deploys dedicated teams across specialties such as obstetrics and gynecology, urology, and neurology; Pharmacy Marketing, focusing on prescription release and over-the-counter (OTC) product placement; and Logistics, which provides cGMP-certified warehousing, cold chain management, and end-to-end supply chain solutions. Arich maintains a client network of over 12,000 medical centers, hospitals, and pharmacies across Taiwan. It competes directly with multinational giants Zuellig Pharma and DKSH, as well as local players like Kerry Pharma and Orient EuroPharma, positioning itself as the premier domestic alternative with deep integration into local healthcare channels. Leadership is currently spearheaded by Chairman Chang Ming-Cheng (Stanley Chang), who also serves as a Director and General Manager of the parent entity, Excelsior Medical Co., Ltd. (4104.TW). The management team includes General Manager Biao Shih-Wei, a Certified Public Accountant with an MBA from National Chengchi University and prior leadership experience at AbbVie, and Chief Financial Officer Lin Yi-Wen, who brings extensive auditing and financial management expertise from Deloitte & Touche. Founded in 1960 and a member of the Excelsior Healthcare Group since 2009, Arich is bolstered by strategic international partnerships, including a long-standing joint venture with the China National Pharmaceutical Group (Sinopharm) and distribution agreements with global principals such as Pfizer, Bayer, and Takeda.